TM TMDX TransMedics Group, Inc. Loading... : Bullish and Bearish Analyst Opinions

Author calls TMDX and NOW "juicy" from a high-quality list but uses watchlist language rather than stating a personal position or forward call.

Buy TMDX as its Organ Care System directly addresses a structural organ shortage problem with a differentiated, transformative medtech platform; strong revenue growth supports the risk/reward case.

The author explicitly states a bullish view on TMDX in a direct reply, indicating a forward-looking positive stance on the stock.

Author explicitly states buying TMDX after a 20% pullback following its earnings release. Sharp post-earnings drops often create entry points if the selloff is overdone; author sees value in the dip. Bet on mean reversion/earnings reaction fade, expecting the stock to recover as market digests results. Earnings miss was fundamental – further downside if guidance weak; sector headwinds in medical devices. TICKER - BN - LONG | confidence: 0.55 | sentiment: +0.40 Speaker: u/Invester1982 Thesis: Author says "I really like BN" with no additional explanation. BN (Brookfield Corp) is a diversified asset manager with a history of compounding; personal liking suggests a perceived value opportunity. Implied long bias based on general enthusiasm, but lacks specific catalyst. No reasoning given; exposure to cyclical assets; market risk.